Abstract
This review focuses on HDL function in modulating LDL oxidation and LDL-induced inflammation. Dysfunctional HDL has been identified in animal models and humans with chronic inflammatory diseases including atherosclerosis. The loss of antiinflammatory function correlated with a loss of function in reverse cholesterol transport. In animal models and perhaps in humans, dysfunctional HDL can be improved by apoA-I mimetic peptides that bind oxidized lipids with high affinity.
Highlights
This review focuses on HDL function in modulating LDL oxidation and LDL-induced inflammation
We reported that cultures of human aortic endothelial cells and smooth muscle cells could oxidize LDL even in the presence of antioxidant containing serum inducing the cells to produce monocyte chemoattractant-1 (MCP-1) [6]
HDL-associated enzymes was reduced in rabbits and humans during the course of an acute phase reaction, resulting in HDL that increased cell-mediated LDL oxidation and increased MCP-1 production
Summary
This review focuses on HDL function in modulating LDL oxidation and LDL-induced inflammation. HDL-associated enzymes was reduced in rabbits and humans during the course of an acute phase reaction, resulting in HDL that increased cell-mediated LDL oxidation and increased MCP-1 production. We reported [10] that apolipoprotein (apo)A-I and an apoA-I peptide mimetic removed seeding molecules from human LDL, rendering the LDL resistant to oxidation by human artery wall cells.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.